> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection on Generic Drug Correspondence
- URL: https://www.fdaweb.com/info-collection-on-generic-drug-correspondence-2/
- Published: 2023-04-11T12:00:00.000Z
- Updated: 2026-09-14T18:24:57.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5154184

*Federal Register* notice: FDA is seeking comments on an information collection revision entitled “Generic Drug User Fee Program; Controlled Correspondence.” The collection is being revised to include recommendations found in agency guidance that discusses the process by which generic drug manufacturers and related industry or their representatives can request information related to generic drug development. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2023-04-11/pdf/2023-07527.pdf?ref=fdaweb.com).